StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RVMDBullishAnalyst Target Updateanalyst
High materiality7/10

RVMD Revolution Medicines price target raised to $192.10 from $181 at Wedbush

Jul 23, 2026, 10:43 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Wedbush raises RVMD target to $192.10; current price $190.94; priceChangeSinceSignal +1.22.

  • Wedbush raises RVMD target to $192.10.

Key facts

  1. 01

    Target: $192.1

  2. 02

    Posted price: $190.94

  3. 03

    Analyst firm: Wedbush

  4. 04

    Analyst: Robert Driscoll

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.